PYXIS ONCOLOGY INC
Institutional coverage
71 13F filers hold $PYXS.
13F holders
71
Insider buys · 90d
0
Congress · 90d
0
Smart Money · top-200 alpha cohort
2 holders · Q1 2026Fewer than 3 top-performer holders hold this ticker — not enough signal for a Smart-Money commentary this week. The institutional holders table below shows the full picture.
Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.
Institutional holders
Top 10 of 71 · Source: 13F-HR01
Novo Holdings A/S
0.32% of portfolio
4,997,333 sh
02
Jennison Associates LLC
3.86% of portfolio
2,161,014 sh
03
Madison Asset Management, LLC
0.23% of portfolio
1,010,510 sh
04
Marshall & Sullivan Inc.
—
921,994 sh
05
Laurion Capital Management LP
0.07% of portfolio
896,263 sh
06
Eads & Heald Wealth Management
—
888,680 sh
07
Sierra Ocean, LLC
0.03% of portfolio
503,214 sh
08
Minneapolis Portfolio Management Group, LLC
—
442,310 sh
09
Evergreen Capital Management LLC
—
397,625 sh
10
Foundry Financial Group, Inc.
0.07% of portfolio
326,810 sh
Insider activity · last 90 days
No insider activity
No Form 4 filings on record for $PYXS in the recent window.
Congress trades · last 90 days
No Congress trades
No STOCK Act filings reference $PYXS in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 10:10 UTC.